Revelation Biosciences, Inc. (REVB) NASDAQ

3.17

+0.0746(+2.41%)

Updated at May 09 10:00AM

Currency In USD

Valuation

Market Cap12.66M
Enterprise Value6.16M
P/E Ratio-0.07
PEG Ratio-0
Price/Sales Ratio107.43
Price/Book Ratio0
Enterprise/Revenue-133.6
Enterprise/EBITDA0.45

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterDecember 31, 2024

Profitability

Profit Margin-557.73
Operating Margin-295.77

Management Effectiveness

Return On Assets-2.27
Return On Equity-0.01

Income Statement

Revenue0
Revenue/Share0.08
Gross Profit0
EBITDA-15.01M
Net Income-15.04B
Diluted EPS-8,768.31

Balance Sheet

Total Cash6.5M
Total Cash/Share18.76
Total Debt0
Total Debt/Equity0
Current Ratio3.43
Book Value Per Share13.59

Price History

52-Week Change-90.91
52-Week High60.8
52-Week Low2.36
Moving Average 50 Days3.08
Moving Average 200 Days9.75

Statistics

Average Volume120,449
Shares Outstanding905,228
% Held by Institutions0.3

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:16
Last Split DateJanuary 28, 2025